Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hercules vs Herceptin in HER2+ Metastatic Breast Cancer
NCT02472964Phase 3Completed
- Sponsor
- Mylan
- Start
- Jul 2012
- Primary completion
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 15
01
Overview
A Phase 3 trial of narsoplimab in HER2-positive metastatic breast cancer, sponsored by Mylan. Started Jul 2012; status: completed.
02
Drugs
narsoplimab
03
Conditions
HER2-positive metastatic breast cancer
Beyond the preview
Go deeper on NCT02472964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02472964.